These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


152 related items for PubMed ID: 15510594

  • 1. Patient Notes: motion sickness.
    Setness PA, Van Beusekom M.
    Postgrad Med; 2004 Oct; 116(4):64. PubMed ID: 15510594
    [No Abstract] [Full Text] [Related]

  • 2. A comparison of motion sickness remedies in severe sea conditions.
    Gahlinger PM.
    Wilderness Environ Med; 2000 Oct; 11(2):136-7. PubMed ID: 10921365
    [No Abstract] [Full Text] [Related]

  • 3. Psychophysiological aspects of motion sickness.
    Murray JB.
    Percept Mot Skills; 1997 Dec; 85(3 Pt 2):1163-7. PubMed ID: 9450266
    [Abstract] [Full Text] [Related]

  • 4. Theory of antimotion sickness drug mechanisms.
    Wood CD, Graybiel A.
    Aerosp Med; 1972 Mar; 43(3):249-52. PubMed ID: 4402925
    [No Abstract] [Full Text] [Related]

  • 5. Further experiments on the prevention of motion sickness.
    GLASER EM, HERVEY GR.
    Lancet; 1952 Mar 08; 1(6706):490-2. PubMed ID: 14898786
    [No Abstract] [Full Text] [Related]

  • 6. Stimulation of the semicircular canals via the rotary chair as a means to test pharmacologic countermeasures for space motion sickness.
    Dornhoffer J, Chelonis JJ, Blake D.
    Otol Neurotol; 2004 Sep 08; 25(5):740-5. PubMed ID: 15354005
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Motion illness.
    Hervey GR.
    Trans Med Soc Lond; 2004 Sep 08; 101():14-20. PubMed ID: 6152833
    [No Abstract] [Full Text] [Related]

  • 9. [Prevention and treatment of motion sickness].
    Marks E, Swiecicki W.
    Wiad Lek; 1974 Jan 01; 27(1):37-42. PubMed ID: 4152152
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacology of motion sickness.
    Lucot JB.
    J Vestib Res; 1998 Jan 01; 8(1):61-6. PubMed ID: 9416591
    [No Abstract] [Full Text] [Related]

  • 13. Treatment of severe motion sickness with antimotion sickness drug injections.
    Graybiel A, Lackner JR.
    Aviat Space Environ Med; 1987 Aug 01; 58(8):773-6. PubMed ID: 3632537
    [Abstract] [Full Text] [Related]

  • 14. Scopolamine for preventing and treating motion sickness.
    Spinks AB, Wasiak J, Villanueva EV, Bernath V.
    Cochrane Database Syst Rev; 2004 Aug 01; (3):CD002851. PubMed ID: 15266468
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the effects of a selective muscarinic receptor antagonist and hyoscine (scopolamine) on motion sickness, skin conductance and heart rate.
    Golding JF, Stott JR.
    Br J Clin Pharmacol; 1997 Jun 01; 43(6):633-7. PubMed ID: 9205824
    [Abstract] [Full Text] [Related]

  • 16. Prevention of experimental motion sickness by scopolamine absorbed through the skin.
    Graybiel A, Knepton J, Shaw J.
    Aviat Space Environ Med; 1976 Oct 01; 47(10):1096-100. PubMed ID: 791234
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms of antimotion sickness drugs.
    Wood CD, Manno JE, Wood MJ, Manno BR, Redetzki HM.
    Aviat Space Environ Med; 1987 Sep 01; 58(9 Pt 2):A262-5. PubMed ID: 3675502
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.